SlideShare una empresa de Scribd logo

The State of Clinical Development - Globalization

•Descargar como PPT, PDF•
•
TTC, llc
TTC, llc

CROs in Today's Drug Development - Douglas Peddicord January 11, 2012

Empresariales
1 de 22
The State of Clinical Development - Globalization January 11, 2011 Doug Peddicord, PhD Executive Director
ACRO ,[object Object],[object Object],[object Object],[object Object],[object Object]
The Top CROs (as of 10-16-11) Sources: Scrip INC Kendle Pharmanet I3 InVentiv Health
Major Pharma and CRO Clinical Headcount Source: Tufts CSDD analysis
ACRO Member Company Expansion: 2010
ACRO Member Company Expansion: 2011
Increasing Global Site Dispersion Source: Tufts CSDD analysis of Industry-Funded Trials Registered on clinicaltrials.gov 2002-2006 (Mean # of Countries) 2006-2010 (Mean # of Countries) Phase I Clinical Trial 2 2 Phase II Clinical Trial 11 18 Phase III Clinical Trial 19 34
A Global Enterprise – Current and Recently Completed Trials Source: ClinicalTrials.gov
Why Conduct Clinical Trials Around The World? ,[object Object],[object Object],[object Object],[object Object]
Globalization - Advantages ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Globalization - Challenges ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Globalization - Concerns ,[object Object],[object Object],[object Object],[object Object]
NBAC 2001 Report – selected recommendations ,[object Object],[object Object],[object Object],[object Object]
More from NBAC ,[object Object],[object Object],[object Object],[object Object],[object Object]
Going Beyond Business Considerations and Policy Recommendations ,[object Object],[object Object]
Comparison of Participating Sites and Subjects Across Various Regions
Demographic and Other Study Details ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Summary of Findings ,[object Object],[object Object],[object Object]
The Next Research Project: 2011-2012 ,[object Object],[object Object],[object Object],[object Object]
Assessing Global Quality at the Investigator/Site Level ,[object Object],[object Object],[object Object]
Aligning The Incentives ,[object Object],[object Object],[object Object]
Thank You! ,[object Object],[object Object],[object Object],[object Object]

Recomendados

FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...
FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...
FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...MedicReS
 
Introduction to clinical sas
Introduction to clinical sasIntroduction to clinical sas
Introduction to clinical sasVijayaraghava Karpurapu
 
Clinical SAS Programming | SAS Training | Big Data | Hadoop | Business Analyt...
Clinical SAS Programming | SAS Training | Big Data | Hadoop | Business Analyt...Clinical SAS Programming | SAS Training | Big Data | Hadoop | Business Analyt...
Clinical SAS Programming | SAS Training | Big Data | Hadoop | Business Analyt...Epochresearch
 
OTC Electronic Clinical Trial Recruitment
OTC Electronic Clinical Trial RecruitmentOTC Electronic Clinical Trial Recruitment
OTC Electronic Clinical Trial RecruitmentTECHdotMN
 
Clinical Trial Primer
Clinical Trial PrimerClinical Trial Primer
Clinical Trial PrimerMichael Passanante
 
A Roadmap for SAS Programmers to Clinical Statistical Programming
A Roadmap for SAS Programmers to Clinical Statistical ProgrammingA Roadmap for SAS Programmers to Clinical Statistical Programming
A Roadmap for SAS Programmers to Clinical Statistical ProgrammingMohammad Majharul Alam
 
Clinical Trial Recruitment & Retention
Clinical Trial Recruitment & RetentionClinical Trial Recruitment & Retention
Clinical Trial Recruitment & RetentionAsijit Sen
 
The Business of Genomic Testing by James Crawford
The Business of Genomic Testing by James CrawfordThe Business of Genomic Testing by James Crawford
The Business of Genomic Testing by James CrawfordKnome_Inc
 

Recomendados

FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...
FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...
FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...MedicReS
 
Introduction to clinical sas
Introduction to clinical sasIntroduction to clinical sas
Introduction to clinical sasVijayaraghava Karpurapu
 
Clinical SAS Programming | SAS Training | Big Data | Hadoop | Business Analyt...
Clinical SAS Programming | SAS Training | Big Data | Hadoop | Business Analyt...Clinical SAS Programming | SAS Training | Big Data | Hadoop | Business Analyt...
Clinical SAS Programming | SAS Training | Big Data | Hadoop | Business Analyt...Epochresearch
 
OTC Electronic Clinical Trial Recruitment
OTC Electronic Clinical Trial RecruitmentOTC Electronic Clinical Trial Recruitment
OTC Electronic Clinical Trial RecruitmentTECHdotMN
 
Clinical Trial Primer
Clinical Trial PrimerClinical Trial Primer
Clinical Trial PrimerMichael Passanante
 
A Roadmap for SAS Programmers to Clinical Statistical Programming
A Roadmap for SAS Programmers to Clinical Statistical ProgrammingA Roadmap for SAS Programmers to Clinical Statistical Programming
A Roadmap for SAS Programmers to Clinical Statistical ProgrammingMohammad Majharul Alam
 
Clinical Trial Recruitment & Retention
Clinical Trial Recruitment & RetentionClinical Trial Recruitment & Retention
Clinical Trial Recruitment & RetentionAsijit Sen
 
The Business of Genomic Testing by James Crawford
The Business of Genomic Testing by James CrawfordThe Business of Genomic Testing by James Crawford
The Business of Genomic Testing by James CrawfordKnome_Inc
 
Towse NDDP implications for drug development
Towse NDDP implications for drug developmentTowse NDDP implications for drug development
Towse NDDP implications for drug developmentOffice of Health Economics
 
PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...
PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...
PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...The Statistical and Applied Mathematical Sciences Institute
 
Major healthcare delivery trends 2015
Major healthcare delivery trends 2015Major healthcare delivery trends 2015
Major healthcare delivery trends 2015Usama Malik
 
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...Medpace
 
Trends in clinical research and career gd 09_may20
Trends in clinical research and career gd 09_may20Trends in clinical research and career gd 09_may20
Trends in clinical research and career gd 09_may20Dr. Ganesh Divekar
 
Clinical sas programmer
Clinical sas programmerClinical sas programmer
Clinical sas programmerray4hz
 
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...Bhaswat Chakraborty
 
Clinical trails
Clinical trails Clinical trails
Clinical trails Dineshk117
 
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...Medpace
 
Plan Early for Late Phase Clinical Trials
Plan Early for Late Phase Clinical TrialsPlan Early for Late Phase Clinical Trials
Plan Early for Late Phase Clinical TrialsMedpace
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data ManagementMahesh Koppula
 
Translational medicine
Translational medicineTranslational medicine
Translational medicineHaroon Rashid
 
Discussant: Prioritizing Evidence Syntheses
Discussant: Prioritizing Evidence SynthesesDiscussant: Prioritizing Evidence Syntheses
Discussant: Prioritizing Evidence SynthesesCochrane.Collaboration
 
Professor Dipak Kalra Digital Health Assembly 2015
Professor Dipak Kalra Digital Health Assembly 2015Professor Dipak Kalra Digital Health Assembly 2015
Professor Dipak Kalra Digital Health Assembly 2015DHA2015
 
Cortellis for Clinical Trials Intelligence Large Group Training
Cortellis for Clinical Trials Intelligence Large Group TrainingCortellis for Clinical Trials Intelligence Large Group Training
Cortellis for Clinical Trials Intelligence Large Group TrainingMichael Passanante
 
Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019Bhaswat Chakraborty
 
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...Zoe Mitchell
 
Digital Footprint: A Step in Which Direction?
Digital Footprint: A Step in Which Direction?Digital Footprint: A Step in Which Direction?
Digital Footprint: A Step in Which Direction?Zoe Mitchell
 
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...The Statistical and Applied Mathematical Sciences Institute
 
Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...
Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...
Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...Canadian Organization for Rare Disorders
 
Investigator Grants
Investigator GrantsInvestigator Grants
Investigator GrantsTTC, llc
 
Annual State of Clinical Development Costs
Annual State of Clinical Development CostsAnnual State of Clinical Development Costs
Annual State of Clinical Development CostsTTC, llc
 

Más contenido relacionado

La actualidad más candente

Major healthcare delivery trends 2015
Major healthcare delivery trends 2015Major healthcare delivery trends 2015
Major healthcare delivery trends 2015Usama Malik
 
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...Medpace
 
Trends in clinical research and career gd 09_may20
Trends in clinical research and career gd 09_may20Trends in clinical research and career gd 09_may20
Trends in clinical research and career gd 09_may20Dr. Ganesh Divekar
 
Clinical sas programmer
Clinical sas programmerClinical sas programmer
Clinical sas programmerray4hz
 
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...Bhaswat Chakraborty
 
Clinical trails
Clinical trails Clinical trails
Clinical trails Dineshk117
 
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...Medpace
 
Plan Early for Late Phase Clinical Trials
Plan Early for Late Phase Clinical TrialsPlan Early for Late Phase Clinical Trials
Plan Early for Late Phase Clinical TrialsMedpace
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data ManagementMahesh Koppula
 
Translational medicine
Translational medicineTranslational medicine
Translational medicineHaroon Rashid
 
Discussant: Prioritizing Evidence Syntheses
Discussant: Prioritizing Evidence SynthesesDiscussant: Prioritizing Evidence Syntheses
Discussant: Prioritizing Evidence SynthesesCochrane.Collaboration
 
Professor Dipak Kalra Digital Health Assembly 2015
Professor Dipak Kalra Digital Health Assembly 2015Professor Dipak Kalra Digital Health Assembly 2015
Professor Dipak Kalra Digital Health Assembly 2015DHA2015
 
Cortellis for Clinical Trials Intelligence Large Group Training
Cortellis for Clinical Trials Intelligence Large Group TrainingCortellis for Clinical Trials Intelligence Large Group Training
Cortellis for Clinical Trials Intelligence Large Group TrainingMichael Passanante
 
Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019Bhaswat Chakraborty
 
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...Zoe Mitchell
 
Digital Footprint: A Step in Which Direction?
Digital Footprint: A Step in Which Direction?Digital Footprint: A Step in Which Direction?
Digital Footprint: A Step in Which Direction?Zoe Mitchell
 
Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...
Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...
Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...Canadian Organization for Rare Disorders
 

La actualidad más candente (20)

Towse NDDP implications for drug development
Towse NDDP implications for drug developmentTowse NDDP implications for drug development
Towse NDDP implications for drug development
 
PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...
PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...
PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...
 
Major healthcare delivery trends 2015
Major healthcare delivery trends 2015Major healthcare delivery trends 2015
Major healthcare delivery trends 2015
 
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
 
Trends in clinical research and career gd 09_may20
Trends in clinical research and career gd 09_may20Trends in clinical research and career gd 09_may20
Trends in clinical research and career gd 09_may20
 
Clinical sas programmer
Clinical sas programmerClinical sas programmer
Clinical sas programmer
 
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
 
Clinical trails
Clinical trails Clinical trails
Clinical trails
 
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
 
Plan Early for Late Phase Clinical Trials
Plan Early for Late Phase Clinical TrialsPlan Early for Late Phase Clinical Trials
Plan Early for Late Phase Clinical Trials
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data Management
 
Translational medicine
Translational medicineTranslational medicine
Translational medicine
 
Discussant: Prioritizing Evidence Syntheses
Discussant: Prioritizing Evidence SynthesesDiscussant: Prioritizing Evidence Syntheses
Discussant: Prioritizing Evidence Syntheses
 
Professor Dipak Kalra Digital Health Assembly 2015
Professor Dipak Kalra Digital Health Assembly 2015Professor Dipak Kalra Digital Health Assembly 2015
Professor Dipak Kalra Digital Health Assembly 2015
 
Cortellis for Clinical Trials Intelligence Large Group Training
Cortellis for Clinical Trials Intelligence Large Group TrainingCortellis for Clinical Trials Intelligence Large Group Training
Cortellis for Clinical Trials Intelligence Large Group Training
 
Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019
 
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
 
Digital Footprint: A Step in Which Direction?
Digital Footprint: A Step in Which Direction?Digital Footprint: A Step in Which Direction?
Digital Footprint: A Step in Which Direction?
 
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
 
Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...
Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...
Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...
 

Destacado

Investigator Grants
Investigator GrantsInvestigator Grants
Investigator GrantsTTC, llc
 
Annual State of Clinical Development Costs
Annual State of Clinical Development CostsAnnual State of Clinical Development Costs
Annual State of Clinical Development CostsTTC, llc
 
SOC & Research BIlling Compliance
SOC & Research BIlling ComplianceSOC & Research BIlling Compliance
SOC & Research BIlling ComplianceTTC, llc
 
Working with Countries that are Difficult to Negotiate with
Working with Countries that are Difficult to Negotiate withWorking with Countries that are Difficult to Negotiate with
Working with Countries that are Difficult to Negotiate withTTC, llc
 
Observational Studies: Strategic, Operational and Budgetary Considerations
Observational Studies: Strategic, Operational and Budgetary ConsiderationsObservational Studies: Strategic, Operational and Budgetary Considerations
Observational Studies: Strategic, Operational and Budgetary ConsiderationsTTC, llc
 
Future Challenges for Big Pharma
Future Challenges for Big PharmaFuture Challenges for Big Pharma
Future Challenges for Big PharmaTTC, llc
 
Late Phase Study Planning and Budgeting
Late Phase Study Planning and BudgetingLate Phase Study Planning and Budgeting
Late Phase Study Planning and BudgetingTTC, llc
 
Clinical rd presentation 10 jan2012_sharma
Clinical rd presentation 10 jan2012_sharmaClinical rd presentation 10 jan2012_sharma
Clinical rd presentation 10 jan2012_sharmaTTC, llc
 
R&D Productivity and Costs in Today's Health Care Arena - Pat Audet
R&D Productivity and Costs in Today's Health Care Arena - Pat AudetR&D Productivity and Costs in Today's Health Care Arena - Pat Audet
R&D Productivity and Costs in Today's Health Care Arena - Pat AudetTTC, llc
 

Destacado (9)

Investigator Grants
Investigator GrantsInvestigator Grants
Investigator Grants
 
Annual State of Clinical Development Costs
Annual State of Clinical Development CostsAnnual State of Clinical Development Costs
Annual State of Clinical Development Costs
 
SOC & Research BIlling Compliance
SOC & Research BIlling ComplianceSOC & Research BIlling Compliance
SOC & Research BIlling Compliance
 
Working with Countries that are Difficult to Negotiate with
Working with Countries that are Difficult to Negotiate withWorking with Countries that are Difficult to Negotiate with
Working with Countries that are Difficult to Negotiate with
 
Observational Studies: Strategic, Operational and Budgetary Considerations
Observational Studies: Strategic, Operational and Budgetary ConsiderationsObservational Studies: Strategic, Operational and Budgetary Considerations
Observational Studies: Strategic, Operational and Budgetary Considerations
 
Future Challenges for Big Pharma
Future Challenges for Big PharmaFuture Challenges for Big Pharma
Future Challenges for Big Pharma
 
Late Phase Study Planning and Budgeting
Late Phase Study Planning and BudgetingLate Phase Study Planning and Budgeting
Late Phase Study Planning and Budgeting
 
Clinical rd presentation 10 jan2012_sharma
Clinical rd presentation 10 jan2012_sharmaClinical rd presentation 10 jan2012_sharma
Clinical rd presentation 10 jan2012_sharma
 
R&D Productivity and Costs in Today's Health Care Arena - Pat Audet
R&D Productivity and Costs in Today's Health Care Arena - Pat AudetR&D Productivity and Costs in Today's Health Care Arena - Pat Audet
R&D Productivity and Costs in Today's Health Care Arena - Pat Audet
 

Similar a The State of Clinical Development - Globalization

Worldwide comprehensive study of guideline on clinical trial
Worldwide comprehensive study of guideline on clinical trialWorldwide comprehensive study of guideline on clinical trial
Worldwide comprehensive study of guideline on clinical trialRGPV BHOPAL
 
Globalization Of Clinical Trials 2010 Josep M. Badenas
Globalization Of Clinical Trials 2010 Josep M. BadenasGlobalization Of Clinical Trials 2010 Josep M. Badenas
Globalization Of Clinical Trials 2010 Josep M. Badenasjosepmariabadenas
 
Foreign clinical trials (FCTs) for life science startups
Foreign clinical trials (FCTs) for life science startupsForeign clinical trials (FCTs) for life science startups
Foreign clinical trials (FCTs) for life science startupsJulio G. Martinez-Clark
 
Siobhan gaynor patientclinicalresearchtalkdec15
Siobhan gaynor patientclinicalresearchtalkdec15Siobhan gaynor patientclinicalresearchtalkdec15
Siobhan gaynor patientclinicalresearchtalkdec15ipposi
 
Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...Pubrica
 
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiFuture Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiTTC, llc
 
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiFuture Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiTTC, llc
 
Exodon - Company Profile and Service Overview
Exodon - Company Profile and Service OverviewExodon - Company Profile and Service Overview
Exodon - Company Profile and Service OverviewPaul Ernest de Leon
 
What Qualities do Providers Identify as Best for Point of Care STI Tests and ...
What Qualities do Providers Identify as Best for Point of Care STI Tests and ...What Qualities do Providers Identify as Best for Point of Care STI Tests and ...
What Qualities do Providers Identify as Best for Point of Care STI Tests and ...CFTCC
 
A CTTI Survey of Current Monitoring Practices
A CTTI Survey of Current Monitoring PracticesA CTTI Survey of Current Monitoring Practices
A CTTI Survey of Current Monitoring PracticesTarget Health, Inc.
 
Cost on development of new drug
Cost on development of new drugCost on development of new drug
Cost on development of new drugDrAsimraza
 
Project Management_DM Presentation
Project Management_DM PresentationProject Management_DM Presentation
Project Management_DM PresentationDaniela Margiotta
 
CURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumCURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumMelanoma Research Foundation
 
Clinical Solutions White Paper
Clinical Solutions White PaperClinical Solutions White Paper
Clinical Solutions White PaperMichael Passanante
 
Soil_ Erosion.ppt
Soil_ Erosion.pptSoil_ Erosion.ppt
Soil_ Erosion.pptAKVerma37
 

Similar a The State of Clinical Development - Globalization (20)

Worldwide comprehensive study of guideline on clinical trial
Worldwide comprehensive study of guideline on clinical trialWorldwide comprehensive study of guideline on clinical trial
Worldwide comprehensive study of guideline on clinical trial
 
Globalization Of Clinical Trials 2010 Josep M. Badenas
Globalization Of Clinical Trials 2010 Josep M. BadenasGlobalization Of Clinical Trials 2010 Josep M. Badenas
Globalization Of Clinical Trials 2010 Josep M. Badenas
 
Foreign clinical trials (FCTs) for life science startups
Foreign clinical trials (FCTs) for life science startupsForeign clinical trials (FCTs) for life science startups
Foreign clinical trials (FCTs) for life science startups
 
SDTM Fnal Detail Training
SDTM Fnal Detail TrainingSDTM Fnal Detail Training
SDTM Fnal Detail Training
 
Siobhan gaynor patientclinicalresearchtalkdec15
Siobhan gaynor patientclinicalresearchtalkdec15Siobhan gaynor patientclinicalresearchtalkdec15
Siobhan gaynor patientclinicalresearchtalkdec15
 
Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...
 
Clinical research
Clinical researchClinical research
Clinical research
 
Elite research network 2011
Elite research network 2011Elite research network 2011
Elite research network 2011
 
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiFuture Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
 
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiFuture Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
 
Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & ValueHepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
 
Exodon - Company Profile and Service Overview
Exodon - Company Profile and Service OverviewExodon - Company Profile and Service Overview
Exodon - Company Profile and Service Overview
 
What Qualities do Providers Identify as Best for Point of Care STI Tests and ...
What Qualities do Providers Identify as Best for Point of Care STI Tests and ...What Qualities do Providers Identify as Best for Point of Care STI Tests and ...
What Qualities do Providers Identify as Best for Point of Care STI Tests and ...
 
A CTTI Survey of Current Monitoring Practices
A CTTI Survey of Current Monitoring PracticesA CTTI Survey of Current Monitoring Practices
A CTTI Survey of Current Monitoring Practices
 
Cost on development of new drug
Cost on development of new drugCost on development of new drug
Cost on development of new drug
 
Project Management_DM Presentation
Project Management_DM PresentationProject Management_DM Presentation
Project Management_DM Presentation
 
CURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumCURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM Symposium
 
Clinical Solutions White Paper
Clinical Solutions White PaperClinical Solutions White Paper
Clinical Solutions White Paper
 
3.clinical trials
3.clinical trials3.clinical trials
3.clinical trials
 
Soil_ Erosion.ppt
Soil_ Erosion.pptSoil_ Erosion.ppt
Soil_ Erosion.ppt
 

Más de TTC, llc

Investigator-Initiated Studies: Two Stories from the NIH
Investigator-Initiated Studies: Two Stories from the NIHInvestigator-Initiated Studies: Two Stories from the NIH
Investigator-Initiated Studies: Two Stories from the NIHTTC, llc
 
Phase IIIB & IV Studies Reflect the Evolution of Industry Needs & Market Real...
Phase IIIB & IV Studies Reflect the Evolution of Industry Needs & Market Real...Phase IIIB & IV Studies Reflect the Evolution of Industry Needs & Market Real...
Phase IIIB & IV Studies Reflect the Evolution of Industry Needs & Market Real...TTC, llc
 
Compliance and FMV - Seth Whitelaw
Compliance and FMV - Seth WhitelawCompliance and FMV - Seth Whitelaw
Compliance and FMV - Seth WhitelawTTC, llc
 
Compliance and FMV - Karen Lowney
Compliance and FMV - Karen LowneyCompliance and FMV - Karen Lowney
Compliance and FMV - Karen LowneyTTC, llc
 
Standard of Care - Donna Beardsworth
Standard of Care - Donna BeardsworthStandard of Care - Donna Beardsworth
Standard of Care - Donna BeardsworthTTC, llc
 
Emerging Regions - Alan Braverman
Emerging Regions - Alan BravermanEmerging Regions - Alan Braverman
Emerging Regions - Alan BravermanTTC, llc
 
Clinical Trial Costs in Emerging Geographies - Stephen Porter
Clinical Trial Costs in Emerging Geographies - Stephen PorterClinical Trial Costs in Emerging Geographies - Stephen Porter
Clinical Trial Costs in Emerging Geographies - Stephen PorterTTC, llc
 
Effective Global Site Budgeting and Cost Management - Natalie Gosciminski
Effective Global Site Budgeting and Cost Management - Natalie GosciminskiEffective Global Site Budgeting and Cost Management - Natalie Gosciminski
Effective Global Site Budgeting and Cost Management - Natalie GosciminskiTTC, llc
 
Effective Global Site Budgeting and Cost Management - Forrest Swope
Effective Global Site Budgeting and Cost Management - Forrest SwopeEffective Global Site Budgeting and Cost Management - Forrest Swope
Effective Global Site Budgeting and Cost Management - Forrest SwopeTTC, llc
 
Payment Practices, FMV, and Study Performance - Harold Glass
Payment Practices, FMV, and Study Performance - Harold GlassPayment Practices, FMV, and Study Performance - Harold Glass
Payment Practices, FMV, and Study Performance - Harold GlassTTC, llc
 
Two Worlds - Larry Poli
Two Worlds - Larry PoliTwo Worlds - Larry Poli
Two Worlds - Larry PoliTTC, llc
 
Effective Global Site Budgeting and Cost Management - Holly Squires
Effective Global Site Budgeting and Cost Management - Holly SquiresEffective Global Site Budgeting and Cost Management - Holly Squires
Effective Global Site Budgeting and Cost Management - Holly SquiresTTC, llc
 
Standard of Care - Ying Jiang
Standard of Care - Ying JiangStandard of Care - Ying Jiang
Standard of Care - Ying JiangTTC, llc
 

Más de TTC, llc (13)

Investigator-Initiated Studies: Two Stories from the NIH
Investigator-Initiated Studies: Two Stories from the NIHInvestigator-Initiated Studies: Two Stories from the NIH
Investigator-Initiated Studies: Two Stories from the NIH
 
Phase IIIB & IV Studies Reflect the Evolution of Industry Needs & Market Real...
Phase IIIB & IV Studies Reflect the Evolution of Industry Needs & Market Real...Phase IIIB & IV Studies Reflect the Evolution of Industry Needs & Market Real...
Phase IIIB & IV Studies Reflect the Evolution of Industry Needs & Market Real...
 
Compliance and FMV - Seth Whitelaw
Compliance and FMV - Seth WhitelawCompliance and FMV - Seth Whitelaw
Compliance and FMV - Seth Whitelaw
 
Compliance and FMV - Karen Lowney
Compliance and FMV - Karen LowneyCompliance and FMV - Karen Lowney
Compliance and FMV - Karen Lowney
 
Standard of Care - Donna Beardsworth
Standard of Care - Donna BeardsworthStandard of Care - Donna Beardsworth
Standard of Care - Donna Beardsworth
 
Emerging Regions - Alan Braverman
Emerging Regions - Alan BravermanEmerging Regions - Alan Braverman
Emerging Regions - Alan Braverman
 
Clinical Trial Costs in Emerging Geographies - Stephen Porter
Clinical Trial Costs in Emerging Geographies - Stephen PorterClinical Trial Costs in Emerging Geographies - Stephen Porter
Clinical Trial Costs in Emerging Geographies - Stephen Porter
 
Effective Global Site Budgeting and Cost Management - Natalie Gosciminski
Effective Global Site Budgeting and Cost Management - Natalie GosciminskiEffective Global Site Budgeting and Cost Management - Natalie Gosciminski
Effective Global Site Budgeting and Cost Management - Natalie Gosciminski
 
Effective Global Site Budgeting and Cost Management - Forrest Swope
Effective Global Site Budgeting and Cost Management - Forrest SwopeEffective Global Site Budgeting and Cost Management - Forrest Swope
Effective Global Site Budgeting and Cost Management - Forrest Swope
 
Payment Practices, FMV, and Study Performance - Harold Glass
Payment Practices, FMV, and Study Performance - Harold GlassPayment Practices, FMV, and Study Performance - Harold Glass
Payment Practices, FMV, and Study Performance - Harold Glass
 
Two Worlds - Larry Poli
Two Worlds - Larry PoliTwo Worlds - Larry Poli
Two Worlds - Larry Poli
 
Effective Global Site Budgeting and Cost Management - Holly Squires
Effective Global Site Budgeting and Cost Management - Holly SquiresEffective Global Site Budgeting and Cost Management - Holly Squires
Effective Global Site Budgeting and Cost Management - Holly Squires
 
Standard of Care - Ying Jiang
Standard of Care - Ying JiangStandard of Care - Ying Jiang
Standard of Care - Ying Jiang
 

Último

8447779800, Low rate Call girls in Rohini Delhi NCR
8447779800, Low rate Call girls in Rohini Delhi NCR8447779800, Low rate Call girls in Rohini Delhi NCR
8447779800, Low rate Call girls in Rohini Delhi NCRashishs7044
 
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCRashishs7044
 
Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Anamaria Contreras
 
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...ShrutiBose4
 
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu MenzaYouth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu Menzaictsugar
 
Kenya’s Coconut Value Chain by Gatsby Africa
Kenya’s Coconut Value Chain by Gatsby AfricaKenya’s Coconut Value Chain by Gatsby Africa
Kenya’s Coconut Value Chain by Gatsby Africaictsugar
 
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607dollysharma2066
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCRashishs7044
 
Organizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessOrganizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessSeta Wicaksana
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCRashishs7044
 
Market Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMarket Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMintel Group
 
Islamabad Escorts | Call 03070433345 | Escort Service in Islamabad
Islamabad Escorts | Call 03070433345 | Escort Service in IslamabadIslamabad Escorts | Call 03070433345 | Escort Service in Islamabad
Islamabad Escorts | Call 03070433345 | Escort Service in IslamabadAyesha Khan
 
Memorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMMemorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMVoces Mineras
 
IoT Insurance Observatory: summary 2024
IoT Insurance Observatory: summary 2024IoT Insurance Observatory: summary 2024
IoT Insurance Observatory: summary 2024Matteo Carbone
 
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...ictsugar
 
Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesKeppelCorporation
 
Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Riya Pathan
 

Último (20)

8447779800, Low rate Call girls in Rohini Delhi NCR
8447779800, Low rate Call girls in Rohini Delhi NCR8447779800, Low rate Call girls in Rohini Delhi NCR
8447779800, Low rate Call girls in Rohini Delhi NCR
 
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
 
Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.
 
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
 
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCREnjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
 
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu MenzaYouth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
 
Kenya’s Coconut Value Chain by Gatsby Africa
Kenya’s Coconut Value Chain by Gatsby AfricaKenya’s Coconut Value Chain by Gatsby Africa
Kenya’s Coconut Value Chain by Gatsby Africa
 
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
 
Organizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessOrganizational Structure Running A Successful Business
Organizational Structure Running A Successful Business
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
 
Market Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMarket Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 Edition
 
Islamabad Escorts | Call 03070433345 | Escort Service in Islamabad
Islamabad Escorts | Call 03070433345 | Escort Service in IslamabadIslamabad Escorts | Call 03070433345 | Escort Service in Islamabad
Islamabad Escorts | Call 03070433345 | Escort Service in Islamabad
 
Japan IT Week 2024 Brochure by 47Billion (English)
Japan IT Week 2024 Brochure by 47Billion (English)Japan IT Week 2024 Brochure by 47Billion (English)
Japan IT Week 2024 Brochure by 47Billion (English)
 
Memorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMMemorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQM
 
Corporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information TechnologyCorporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information Technology
 
IoT Insurance Observatory: summary 2024
IoT Insurance Observatory: summary 2024IoT Insurance Observatory: summary 2024
IoT Insurance Observatory: summary 2024
 
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
 
Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation Slides
 
Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737
 

The State of Clinical Development - Globalization

  • 1. The State of Clinical Development - Globalization January 11, 2011 Doug Peddicord, PhD Executive Director
  • 2.
  • 3. The Top CROs (as of 10-16-11) Sources: Scrip INC Kendle Pharmanet I3 InVentiv Health
  • 4. Major Pharma and CRO Clinical Headcount Source: Tufts CSDD analysis
  • 5. ACRO Member Company Expansion: 2010
  • 6. ACRO Member Company Expansion: 2011
  • 7. Increasing Global Site Dispersion Source: Tufts CSDD analysis of Industry-Funded Trials Registered on clinicaltrials.gov 2002-2006 (Mean # of Countries) 2006-2010 (Mean # of Countries) Phase I Clinical Trial 2 2 Phase II Clinical Trial 11 18 Phase III Clinical Trial 19 34
  • 8. A Global Enterprise – Current and Recently Completed Trials Source: ClinicalTrials.gov
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16. Comparison of Participating Sites and Subjects Across Various Regions
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.

Notas del editor

  1. As a note, our members have opened 35 new locations in the past five quarters, including 6 in China and 5 in India, so clearly drug development is headed more to the Asia-Pacific region.